These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20488405)

  • 21. The "mini-crush" technique for managing bifurcation lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):85-7. PubMed ID: 19530202
    [No Abstract]   [Full Text] [Related]  

  • 22. Warning: this report does not address heavily calcified coronary arteries.
    Butman SM
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):643. PubMed ID: 20976745
    [No Abstract]   [Full Text] [Related]  

  • 23. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
    Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G
    JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of 2.5-mm sirolimus-eluting stent implantation at lower deployment pressures in very small vessels (<2.5 mm).
    Umeda H; Iwase M; Gochi T; Izawa H; Ishiki R; Inagaki H; Shimizu T; Yokota M; Murohara T
    Coron Artery Dis; 2009 Mar; 20(2):163-8. PubMed ID: 19293669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The process of bringing new drug-eluting stents to market will they see the light of day?
    Holmes DR; Patel M
    JACC Cardiovasc Interv; 2008 Oct; 1(5):533-4. PubMed ID: 19463355
    [No Abstract]   [Full Text] [Related]  

  • 26. Images in intervention. Optical coherence tomography findings in very late (4 years) paclitaxel-eluting stent thrombosis.
    Schinkel AF; Barlis P; van Beusekom HM; Serruys PW; Regar E
    JACC Cardiovasc Interv; 2008 Aug; 1(4):449-51. PubMed ID: 19463343
    [No Abstract]   [Full Text] [Related]  

  • 27. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
    Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
    JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repetita iuvant.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):468-9. PubMed ID: 18819144
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary stent fracture: the hidden truth of a problem more common than stent thrombosis.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):88-9. PubMed ID: 19089948
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stent expansion as a mechanical parameter to predict late stent patency: back to the basics.
    Honda Y; Fitzgerald PJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1276-8. PubMed ID: 20129556
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
    Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating the left main bifurcation lesion: the "three stent solution".
    Uretsky BF
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):42-3. PubMed ID: 19089935
    [No Abstract]   [Full Text] [Related]  

  • 35. A generation 2.5 drug-eluting stent?
    Ellis SG
    JACC Cardiovasc Interv; 2009 Oct; 2(10):986-8. PubMed ID: 19850259
    [No Abstract]   [Full Text] [Related]  

  • 36. The artisan approach for stenting bifurcation lesions.
    Colombo A; Latib A
    JACC Cardiovasc Interv; 2010 Jan; 3(1):66-7. PubMed ID: 20129571
    [No Abstract]   [Full Text] [Related]  

  • 37. Feasibility, safety, and efficacy of a novel polymeric pimecrolimus-eluting stent: traditional pre-clinical safety end points failed to predict 6-month clinical angiographic results.
    Ormiston JA; Webster MW; Schwartz RS; Gladding P; Stewart JT; Kay IP; Ruygrok PN; Hatrick R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1017-24. PubMed ID: 19850264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events.
    Leon MB; Allocco DJ; Dawkins KD; Baim DS
    JACC Cardiovasc Interv; 2009 Jun; 2(6):504-12. PubMed ID: 19539253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.